Prenatal Diagnosis of Congenital Lipoid Adrenal Hyperplasia (CLAH) by Molecular Genetic Testing in Korean Siblings

Congenital lipoid adrenal hyperplasia (CLAH) is caused by mutations to the steroidogenic acute regulatory protein (StAR) gene associated with the inability to synthesize all adrenal and gonadal steroids. Inadequate treatment in an infant with this condition may result in sudden death from an adrenal crisis. We report a case in which CLAH developed in Korean siblings; the second child was prenatally diagnosed because the first child was affected and low maternal serum estriol was detected in a prenatal screening test. To our knowledge, this is the first prenatal diagnosis of the Q258X StAR mutation, which is the only consistent genetic cluster identified to date in Japanese and Korean populations.

[1]  W. Chung,et al.  Prenatal diagnosis of congenital lipoid adrenal hyperplasia (CLAH) by estriol amniotic fluid analysis and molecular genetic testing , 2008, Prenatal diagnosis.

[2]  W. Miller.  Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter. , 2007, Biochimica et biophysica acta.

[3]  J. Canick,et al.  Second trimester serum markers. , 2005, Seminars in perinatology.

[4]  M. New,et al.  Congenital hypopituitarism as a cause of undetectable estriol levels in the maternal triple-marker screen. , 2003, The Journal of clinical endocrinology and metabolism.

[5]  J. Opitz,et al.  Cholesterol and development: the RSH ("Smith-Lemli-Opitz") syndrome and related conditions. , 2002, Pediatric pathology & molecular medicine.

[6]  J. Haddow,et al.  Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome , 2002, Journal of medical screening.

[7]  R. Auchus.  The genetics, pathophysiology, and management of human deficiencies of P450c17. , 2001, Endocrinology and metabolism clinics of North America.

[8]  W. Miller,et al.  Mutations in the steroidogenic acute regulatory protein (StAR) in six patients with congenital lipoid adrenal hyperplasia. , 2000, The Journal of clinical endocrinology and metabolism.

[9]  R. Auchus,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society COMMENTARY Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action* , 2022 .

[10]  P. Donohoue,et al.  Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita. , 1999, The Journal of clinical endocrinology and metabolism.

[11]  H. Yoo,et al.  Molecular and Clinical Characterization of Korean Patients with Congenital Lipoid Adrenal Hyperplasia , 1998, Journal of pediatric endocrinology & metabolism : JPEM.

[12]  K. Tachibana,et al.  Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. , 1997, Human molecular genetics.

[13]  W. Miller,et al.  The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. , 1996, The New England journal of medicine.

[14]  A. Rogol,et al.  Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. , 1995, Science.

[15]  S. Black,et al.  Prenatal diagnosis of congenital lipoid adrenal hyperplasia. , 1995, The Journal of clinical endocrinology and metabolism.

[16]  I. Bartels,et al.  Prenatal detection of X‐linked ichthyosis by maternal serum screening for down syndrome , 1994, Prenatal diagnosis.

[17]  P. Hensleigh,et al.  Congenital X-linked adrenal hypoplasia. , 1978, Obstetrics and gynecology.